SCHEMBL4130410

SCHEMBL4130410

CCCc1n[nH]c2c(=O)[nH]c(N(Cc3ccc(F)cc3)CC3CCCCC3)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.34
TSHR P16473 4/20 0.33
KMT2A Q03164 3/20 0.33
GRIN2A Q12879 2/20 0.33
MEN1 O00255 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 3/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 1/20 0.32
GRIA2 P42262 1/20 0.31
PKM P14618 1/20 0.31
ALPL P05186 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CTSL P07711 1/20 0.30
HTT P42858 1/20 0.30
LTC4S Q16873 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4136313 0.80 PDE5A (0.36) TSHRKMT2AGRIN2AMEN1SMN1; SMN2
SCHEMBL8032543 0.79 HSP90AA1 (0.35) PARP1ATM
SCHEMBL8027507 0.77 PDE10A (0.38) TSHRKMT2ASMN1; SMN2NPSR1TP53
SCHEMBL4117755 0.73 KDM4E (0.41) TSHRKMT2AGRIN2AMEN1SMN1; SMN2
SCHEMBL4126072 0.70 PDE5A (0.42) KMT2AMEN1SMN1; SMN2KDM4EALDH1A1
SCHEMBL8049072 0.67 PDE5A (0.48) KMT2AMEN1ALDH1A1
SCHEMBL8037857 0.66 PDE5A (0.42) KMT2AMEN1ALDH1A1PDE9A
SCHEMBL4136868 0.66 PDE5A (0.44) KMT2AMEN1ALDH1A1
SCHEMBL4898303 0.64 PDE5A (0.48) KMT2AMEN1KDM4EALDH1A1
SCHEMBL8237549 0.64 CCNE2 (0.35) PARP1KMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed